Engineering a designer immunotherapy

Affiliations

Comment

Crystal L Mackall. Science. 2018.

. 2018 Mar 2;359(6379):990-991.

doi: 10.1126/science.aas9434.

¹ Department of Pediatrics and Medicine, and Stanford Cancer Institute, 265 Campus Way, G3141A, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.

No abstract available

Comment on

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.
Sockolosky JT, Trotta E, Parisi G, Picton L, Su LL, Le AC, Chhabra A, Silveria SL, George BM, King IC, Tiffany MR, Jude K, Sibener LV, Baker D, Shizuru JA, Ribas A, Bluestone JA, Garcia KC. Sockolosky JT, et al. Science. 2018 Mar 2;359(6379):1037-1042. doi: 10.1126/science.aar3246. Science. 2018. PMID: 29496879 Free PMC article.